Visiongain has published a new report on Oral Contraceptive Pills Market Report 2021-2031: Forecasts By Type (Combination, Progestin Only, and Others), By Age (15-19, 20-29, 30-39, and 40-49), By Drug Type (Generic Drug, and Branded Drug), By End User (Hospitals, Homecare, Specialty Clinics, Academic and Research Institute, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS, COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/oral-contraceptive-pills-market-2021/#download_sampe_div
COVID-19 Impact on Oral Contraceptive Pills Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Oral Contraceptive Pills market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:
Market Drivers
Increasing Incidence of Unintended Pregnancies
An unintended pregnancy is a pregnancy in which either no more children are desired or unwanted, such as the pregnancy occurring when no children or the pregnancy is mistimed. Incidence of unintended pregnancies is increasing very significantly as compared to last few years and it is expected that incidence of unintended pregnancies will increase during forecast period, due to lack of awareness and sex education. Increasing incidence of unintended pregnancies cases is increasing demand of oral contraceptive pills to prevent unintended pregnancies. Due to which increasing incidence of unintended pregnancies is working as a driver for the oral contraceptive pills market.
Increasing Government Initiative and Awareness Program
Governments from all the world are increasing their focus on population control and unintended pregnancies and are taking necessary steps to control population and prevent unintended pregnancies. Governments in developing nations are creating more and more awareness programs from the last few years to control the population and prevent unintended pregnancies. Increasing government initiative and awareness program is expected to increase awareness and sex education among public which is expected to create demand of oral contraceptive pills new for controlling population and prevent unintended pregnancies, due to this reason the factor is working as a driver for the oral contraceptive pills market.
Get Detailed TOC @ https://www.visiongain.com/report/oral-contraceptive-pills-market-2021/#download_sampe_div
Market Opportunities
Increasing Strategic Initiatives in Oral Contraceptive Pills Market
Manufactures present in the market are taking various strategic initiatives such as mergers & acquisitions, product launches and press conference & events. With these strategic initiatives the manufactures are focusing to enhance their product portfolio to increase their revenue generation in the market. Increase in the number of products will create competition for better, accurate and most effective, economic oral contraceptive pills. Availability of better, accurate and most effective, economic oral contraceptive pills will help to increase preference for oral contraceptive pills as compared to other alternative methods available in the market. Due to this reason increasing strategic initiatives in the oral contraceptive pills market is expected to create new opportunities for the oral contraceptive pills market.
Competitive Landscape
Top companies (Allergan plc, Bayer AG, Johnson & Johnson Services, Inc., and Mankind Pharma Ltd.,) constitute more than XX% share of the global Oral Contraceptive Pills market. Other companies profiled in the report include: Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Piramal Enterprises, Syzygy Healthcare LLC, Cipla Limited and Other Company among) others Some of the key developments are listed below:
- In 2020, Theramex and Merck & Co., Inc., formed an agreement for Zoely, which is a patented oral contraceptive. Under the new agreement Theramex will market Zoely up to more than 50 on a global basis. The agreement is expected to help the company to its market share in the oral contraceptive pills market.
- In 2018, Aurobindo Pharma Limited launched Tri-Mili and Mili, which are oral contraceptive tablets. With the launch of the new drug the company is expected to increase their market presence in the oral contraceptive pills market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Oral Contraceptive Pills Market and leading companies. You will find data, trends and predictions.
Find more Visiongain research reports on Therapeutic Drug Sector click on the following links:
- Osteoporosis Drugs Market
- Parenteral Nutrition Market
- Meningococcal Vaccines Market
- Batten Disease Treatment Market
- Pain Management Therapeutics Market
- Basal Cell Carcinoma Treatment Market
- Biopharmaceuticals Contract Manufacturing Market
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact:
Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.
